Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharamvir Jain

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 18, 2014
Ibrutinib: a new frontier in the treatment of chronic lymphocytic leukemia by Bruton's tyrosine kinase inhibitionAjoy Lawrence Dias, Dharamvir Jain
Current Oncology Reports|November 4, 2016
Age-related Disparity: Breast Cancer in the ElderlyRahul Gosain, YaoYao Pollock, Dharamvir Jain
The Australasian Journal of Dermatology|October 16, 2008
Therapy-related leukaemia cutis: a reviewSarah Weinel, Janine Malone, Dharamvir Jain, et al.
The Australasian Journal of Dermatology|January 31, 2009
Leukaemia cutis in a patient treated for breast cancerSarah Weinel, Janine Malone, Dharamvir Jain, et al.
Seminars in Oncology|November 18, 2018
Management of immunotherapy toxicities in older adultsShruti Bhandari, Amitoj S Gill, Cesar A Perez, et al.
American Journal of Clinical Oncology|September 1, 2010
Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution studyAnthony E Dragun, Jianmin Pan, Shesh N Rai, et al.
Medical Oncology (Northwood, London, England)|December 17, 2002
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case reportGeorge Marcoullis, Lool Abebe, Dharamvir Jain, et al.
Medical Oncology (Northwood, London, England)|January 13, 2004
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosisKevin P O'Boyle, Ashwin Murigeppa, Dharamvir Jain, et al.
American Journal of Clinical Oncology|May 31, 2012
Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer centerAnthony E Dragun, Jianmin Pan, Elizabeth C Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cardiovascular & Hematological Agents in Medicinal Chemistry|January 18, 2014
Ibrutinib: a new frontier in the treatment of chronic lymphocytic leukemia by Bruton's tyrosine kinase inhibitionAjoy Lawrence Dias, Dharamvir Jain
Current Oncology Reports|November 4, 2016
Age-related Disparity: Breast Cancer in the ElderlyRahul Gosain, YaoYao Pollock, Dharamvir Jain
The Australasian Journal of Dermatology|October 16, 2008
Therapy-related leukaemia cutis: a reviewSarah Weinel, Janine Malone, Dharamvir Jain, et al.
The Australasian Journal of Dermatology|January 31, 2009
Leukaemia cutis in a patient treated for breast cancerSarah Weinel, Janine Malone, Dharamvir Jain, et al.
Seminars in Oncology|November 18, 2018
Management of immunotherapy toxicities in older adultsShruti Bhandari, Amitoj S Gill, Cesar A Perez, et al.
American Journal of Clinical Oncology|September 1, 2010
Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution studyAnthony E Dragun, Jianmin Pan, Shesh N Rai, et al.
Medical Oncology (Northwood, London, England)|December 17, 2002
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case reportGeorge Marcoullis, Lool Abebe, Dharamvir Jain, et al.
Medical Oncology (Northwood, London, England)|January 13, 2004
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosisKevin P O'Boyle, Ashwin Murigeppa, Dharamvir Jain, et al.
American Journal of Clinical Oncology|May 31, 2012
Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer centerAnthony E Dragun, Jianmin Pan, Elizabeth C Riley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2023
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.3Ishmael A Jaiyesimi, Dwight H Owen, Nofisat Ismaila, et al.
Pageof 3